Correlation Between Dermata Therapeutics and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and Aerovate Therapeutics, you can compare the effects of market volatilities on Dermata Therapeutics and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Aerovate Therapeutics.
Diversification Opportunities for Dermata Therapeutics and Aerovate Therapeutics
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Dermata and Aerovate is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Dermata Therapeutics and Aerovate Therapeutics
Given the investment horizon of 90 days Dermata Therapeutics is expected to generate 32.36 times less return on investment than Aerovate Therapeutics. In addition to that, Dermata Therapeutics is 2.58 times more volatile than Aerovate Therapeutics. It trades about 0.0 of its total potential returns per unit of risk. Aerovate Therapeutics is currently generating about 0.12 per unit of volatility. If you would invest 186.00 in Aerovate Therapeutics on November 2, 2024 and sell it today you would earn a total of 76.00 from holding Aerovate Therapeutics or generate 40.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dermata Therapeutics vs. Aerovate Therapeutics
Performance |
| Timeline |
| Dermata Therapeutics |
| Aerovate Therapeutics |
Dermata Therapeutics and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dermata Therapeutics and Aerovate Therapeutics
The main advantage of trading using opposite Dermata Therapeutics and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.| Dermata Therapeutics vs. Zura Bio Limited | Dermata Therapeutics vs. Phio Pharmaceuticals Corp | Dermata Therapeutics vs. Sonnet Biotherapeutics Holdings | Dermata Therapeutics vs. 180 Life Sciences |
| Aerovate Therapeutics vs. Adagene | Aerovate Therapeutics vs. Acrivon Therapeutics, Common | Aerovate Therapeutics vs. Rezolute | Aerovate Therapeutics vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |